Stratification of the impact of inappropriate empirical antimicrobial therapy for gram-negative bloodstream infections by predicted prognosis

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 1, 2015, Pages 245-250

  Cain, Sarah E ^a   Kohn, Joseph ^b   Bookstaver, P Bron ^c   Albrecht, Helmut ^a   Al Has, Majdi N ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Department of Clinical Pharmacy Palmetto Health Richland ^*  (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BLOODSTREAM INFECTION MORTALITY RISK SCORE; COHORT ANALYSIS; DRUG BIOAVAILABILITY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEMALE; FOLLOW UP; GRAM NEGATIVE BLOODSTREAM INFECTION; GRAM NEGATIVE INFECTION; HUMAN; INAPPROPRIATE EMPIRICAL ANTIMICROBIAL THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; BACTEREMIA; BLOOD; CLINICAL TRIAL; EPIDEMIOLOGY; GRAM-NEGATIVE BACTERIAL INFECTIONS; INAPPROPRIATE PRESCRIBING; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; SOUTH CAROLINA; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INAPPROPRIATE PRESCRIBING; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SOUTH CAROLINA; TREATMENT OUTCOME;

EID: 84920182236     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03935-14     Document Type: Article

References (22)

1. Goto M, Al-Hasan MN. 2013. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect 19:501-509. http://dx.doi.org/10.1111/1469-0691 .12195.
2. Bryan CS, Reynolds KL, Brenner ER. 1983. Analysis of 1,186 episodes of Gram-negative bacteremia in non-university hospital: the effects of antimicrobial therapy. Rev Infect Dis 5:629-638. http://dx.doi.org/10.1093 /clinids/5.4.629.
3. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. 2010. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 54:4851-4863. http://dx.doi.org/10.1128/AAC.00627-10.
4. Retamar P, Portillo MM, López-Prieto MD, Rodríguez-López F, de Cueto M, García MV, Gómez MJ, del Arco A, Muñoz A, Sánchez-Porto A, Torres-Tortosa M, Martín-Aspas A, Arroyo A, García-Figueras C, Acosta F, Corzo JE, León-Ruiz L, Escobar-Lara T, Rodríguez-Baño J, SAEI/Bacteremia Group SAMPAC. 2012. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother 56:472-478. http://dx.doi.org/10.1128/AAC.00462-11.
5. Paul M, Fraser AA, Leibovici L. 2007. Propensity-matched analysis of appropriate empirical antibiotic treatment. Clin Infect Dis 44:1251-1252. http://dx.doi.org/10.1086/513585.
6. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP, Jr, Miller RR, Furuno JP. 2007. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis 45:329-337. http://dx.doi.org /10.1086/519283.
7. Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. 2013. Predictive scoring model of mortality in Gram-negative bloodstream infection. Clin Microbiol Infect 19:948-954. http://dx.doi.org/10.1111/1469-0691 .12085.
8. Al-Hasan MN, Juhn YJ, Bang DW, Yang H-J, Baddour LM. 2014. External validation of Gram-negative bloodstream infection mortality risk score in a population-based cohort. Clin Microbiol Infect 20:886-891. http://dx.doi.org/10.1111/1469-0691.12607.
9. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 140:26-32. http://dx.doi.org/10.7326/0003-4819-140-1 -200401060-00008.
10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. 1988. CDC definitions for nosocomial infections. Am J Infect Control 16:128-140. http://dx.doi.org/10.1016/0196-6553(88)90053-3.
11. Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL, Ma MH, Chen SC, Chen WJ, Chang SC. 2009. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis 64:124-130. http://dx.doi.org/10.1016/j.diagmicrobio.2009.01 .008.
12. Sexton DJ, Miller BA, Anderson DJ. 2011. Measuring the effect of inappropriate initial antibiotic therapy on outcomes of patients with Gramnegative sepsis: an imprecise science. Crit Care Med 39:199-200. http://dx .doi.org/10.1097/CCM.0b013e318202e68f.
13. Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J, ITUBRAS Group, Grupo de Estudio de Infección Hospitalaria, Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2013. Healthcare-associated, com-munity-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 19:962-968. http: //dx.doi.org/10.1111/1469-0691.12089.
14. Yang YS, Ku CH, Lin JC, Shang ST, Chiu CH, Yeh KM, Lin CC, Chang FY. 2010. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect 43:194-199. http://dx.doi.org/10.1016/S1684-1182(10)60031-X.
15. Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD. 2008. Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study. BMC Infect Dis 8:116. http://dx.doi.org/10.1186 /1471-2334-8-116.
16. Lee SS, Kim Y, Chung DR. 2011. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 62:159-164. http://dx.doi.org/10.1016/j.jinf.2010.10.009.
17. Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ, Carmeli Y. 2009. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis 48:580-586. http: //dx.doi.org/10.1086/596709.
18. Cheong HS, Kang CI, Wi YM, Kim ES, Lee JS, Ko KS, Chung DR, Lee NY, Song JH, Peck KR. 2008. Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med 121: 709-714. http://dx.doi.org/10.1016/j.amjmed.2008.03.034.
19. Koliscak LP, Johnson JW, Beardsley JR, Miller DP, Williamson JC, Luther VP, Ohl CA. 2013. Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy. Antimicrob Agents Chemother 57: 5918-5923. http://dx.doi.org/10.1128/AAC.01202-13.
20. Tumbarello M, Trecarichi EM, Bassetti M, De Rosa FG, Spanu T, Di Meco E, Losito AR, Parisini A, Pagani N, Cauda R. 2011. Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob Agents Chemother 55:3485-3490. http://dx.doi.org /10.1128/AAC.00009-11.
21. Shorr AF, Micek ST, Welch EC, Doherty JA, Reichley RM, Kollef MH. 2011. Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med 39:46-51. http://dx.doi.org/10.1097 /CCM.0b013e3181fa41a7.
22. Micek S, Johnson MT, Reichley R, Kollef MH. 2012. An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis. BMC Infect Dis 12:56. http://dx.doi.org/10.1186/1471-2334-12-56.